Drug Type Cell therapy |
Synonyms |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin's lymphoma refractory | Phase 1 | US | 01 Dec 2023 | |
Recurrent Non-Hodgkin Lymphoma | Phase 1 | US | 01 Dec 2023 | |
T-Cell Lymphoma | Phase 1 | US | 06 Nov 2023 | |
Head and Neck Neoplasms | Preclinical | US | 22 Sep 2023 |